Safety and immunogenicity of vaccines against SARS-CoV-2
The mortality rate estimated by the WHO worldwide for COVID-19 has been 5.7%, much higher than other communicable infectious diseases, so it is essential to apply a vaccine to the population to reduce the viral spread, according to the WHO there are 23 projects in clinical phase stage III, such as v...
Збережено в:
| Опубліковано в:: | Archivos Venezolanos de Farmacología y Terapéutica |
|---|---|
| Автори: | , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Sociedad Venezolana de Farmacología Clínica y Terapéutica
2021
|
| Предмети: | |
| Онлайн доступ: | https://www.redalyc.org/articulo.oa?id=55971716011 https://www.redalyc.org/journal/559/55971716011/ https://www.redalyc.org/journal/559/55971716011/html/ https://www.redalyc.org/journal/559/55971716011/55971716011.epub https://www.redalyc.org/journal/559/55971716011/movil https://doi.org/10.5281/zenodo.5839028 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|